Stock Market Blog
Daily stock market analysis, trade alerts, and trading education from Ross Givens and the Traders Agency team.
Stock Market Today: Technology Leads While S&P 500 Slips
Technology led the session while the S&P 500 slips. See the validated market scorecard, sector performance, and what traders are watching next.
Traders, Avoid These “Long Weekend Dangers”
Hey friend, The official employment numbers came in this morning. It showed the economy adding 162,000 jobs for August – far ahead of the expected 53,000. The unemployment rate stayed steady at 4.1%. Let’s see how the markets have been moving. The Daily Direction Note: All indexes closed sharply higher yesterday but ha
Reports: Gold and Silver Selloff Hits on Fed Hike Odds
Gold and silver selloff deepens as strong jobs data revives Fed rate hike odds. See why gold silver prices are falling and what traders watch next.
The FDA Votes September 23rd... This Cancer Stock Could Go PARABOLIC
GRAIL Inc stock faces a binary FDA vote Sept 23rd on Galleri's cancer test. See what could send GRAL parabolic or crashing.
Enterprise Value vs Market Cap: When to Use Each
Enterprise value vs market cap: learn why debt and cash change a company's true price, plus the formula to calculate EV correctly.
Stock Market Today: Financials Leads While S&P 500 Advances
Financials led the session while the S&P 500 advances. See the validated market scorecard, sector performance, and what traders are watching next.
Stop Expecting the Market to Do This
The market can send conflicting signals for a lot longer than traders expect. The trouble starts when you force them into one neat bullish or bearish story.
Why Did Nvidia Acquire Hugging Face for $13B
Why did Nvidia acquire Hugging Face? Inside the $12.93B deal, Nvidia's 2nd-biggest ever, and what it means for AI traders now.
Oil Prices and Stock Futures Rattled by Iran
Oil prices and stock futures diverge as Brent tops $95 on US-Iran strikes and yields climb near 2025 highs.
Gap Trading Strategies
Learn a gap trading strategy that classifies gap types, reads pre-market volume, and decides when to fade or ride the move.
Wall Street Says Hair Loss Is the Next Ozempic... I Found the Stock to Watch
Veradermics stock (MANE) posted 4x placebo hair growth data. With 80M cash-paying patients, is this the next big pharma trade?
Stop watching.
Start winning.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.
